Fresenius Medical Care AG & Co. (NYSE:FMS) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research note issued to investors on Monday, The Fly reports. Shares of Fresenius Medical Care AG & Co. (NYSE:FMS) traded down 2.29% on Monday, hitting $40.88. 181,358 shares of […]
